Sensorion Announces the Publication of Its 2022 Annual Finan

30.03.2023 - Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that its Annual Financial Report for the year ending December 31, 2022, is available ...

Related Keywords

France , Lang Schwarz , Professeur Joseph Blayac , Institut Pasteur , Company Headquarters , Management Report , Annual Accounts , Financial Statements , Annual Financial Report , Financial Information , Cochlear Limited , Sudden Sensorineural , Hearing Loss , Sensorion Stock , Sensorion ,